Strata Critical Medical shows standout revenue growth and a favorable engine-calculated risk/reward setup, but earnings quality red flags, a volatile earnings track record, and ongoing insider selling temper the bullish growth narrative.
Thesis pillars
- Strong Revenue Growth Industry Leader→Stable
- Earnings Quality Red Flag→Stable
- Favorable Risk Reward Asymmetry→Stable
- +2 more pillars — see the Why tab for full reasoning
Pillars as of Jul 5, 2026, based on the 10-K filed Mar 3, 2026
Strata Critical Medical, Inc. (SRTA) Stock Analysis
Inst Constrain edge
Healthcare · Medical Care Facilities
Hold if already holding. Not a fresh buy at $4.44, but acceptable to hold if already in. Reasons: Market cap $393M below $400M minimum; Value-trap signals (2/5): Margin compression (op margin -686.9%), Material insider selling (10 sells, 0.05% of cap).
Strata Critical Medical (formerly Blade Air Mobility) is a time-critical logistics and clinical services provider to the U.S. transplant industry, operating one of the nation's largest air transport and surgical services networks for transplant hospitals and organ procurement... Read more
Hold if already holding. Not a fresh buy at $4.44, but acceptable to hold if already in. Reasons: Market cap $393M below $400M minimum; Value-trap signals (2/5): Margin compression (op margin -686.9%), Material insider selling (10 sells, 0.05% of cap). Chart setup: No clear chart pattern; technical signals are mixed. Market cap $393M below $400M minimum. Not in investable universe. Score 6.5/10, moderate confidence.
Passes 6/8 gates (favorable risk/reward ratio, clean insider activity, no SEC red flags, news events none recent, semi cycle peak clear, materials cycle peak clear). Fails on weak momentum and earnings proximity 0d<=7d. Suitability: aggressive.
Recent developments
updated 2026-11-02Recent Developments — Strata Critical Medical, Inc.
Latest news
- NEWS Third Point Files 13D Activist Stake in Strata Critical Medical — fiscal.ai Oct 24, 2026
- NEWS Strata Critical Medical Schedules Third Quarter 2026 Earnings Conference Call — fiscal.ai Oct 24, 2026
- NEWS Crude Oil Jumps 3%; Citizens Financial Earnings Top Views — benzinga Oct 16, 2026 neutral
- NEWS Ladder Capital Posts Upbeat Q3 Earnings, Joins Alcoa, Hyster-Yale And Other Big Stocks Moving Higher On Friday — benzinga Oct 16, 2026 positive
- NEWS Third Point Says Acquired Strata Critical Medical's Securities For Investment Purposes And Believe That Common Stock Is — benzinga Oct 15, 2026
Generated 2026-11-02T11:33:17Z.
Upcoming dated catalysts
Thesis
Key Metrics
Quality Signals
Options Flow
Concentration Risks(10-K Item 1A)
- MEDIUMCustomertransplant centers and OPOs10-K Item 1A: 'The transplant ecosystem in the United States is relatively concentrated among a limited number of transplant centers and OPOs'
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Editorial policy
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. People who build TrendMatrix, or entities they control, may hold positions, long or short, in securities it covers, and may trade them at any time. Positions are not disclosed individually. Verdicts are generated by an automated model applied by the same rules to every covered stock, and are not adjusted for any position held by the people who build TrendMatrix. We do not accept payment from issuers for coverage.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Rating Breakdown
3 floor-breakers·2 ceiling hits
No near-term catalyst priced in. Thesis progression will come from fundamentals grinding, not event reaction.static
Quality below the gate floor. Component breakdown shows what dragged the score down.static
Price action weak — below key moving averages, no momentum carry. Needs a base before trend-continuation setups apply.static
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Hold if already holding. Not a fresh buy at $4.44, but acceptable to hold if already in. Reasons: Market cap $393M below $400M minimum; Value-trap signals (2/5): Margin compression (op margin -686.9%), Material insider selling (10 sells, 0.05% of cap). Chart setup: No clear chart pattern; technical signals are mixed. Market cap $393M below $400M minimum. Not in investable universe. Analyst target $8.13 (+83.1%), stop $4.13 (−7.5%), A.R:R 10.2:1. Score 6.5/10, moderate confidence.
Analyst target: $8.13 (+83.1% upside). Analyst target $8.13 (+83.1%), stop $4.13 (−7.5%), A.R:R 10.2:1. Stop-loss: $4.13.
Market cap $393M below $400M minimum; Value-trap signals (2/5): Margin compression (op margin -686.9%), Material insider selling (10 sells, 0.05% of cap).
Strata Critical Medical, Inc. trades at a P/E of N/A (forward N/A). TrendMatrix value score: 9.1/10. Verdict: Hold.
10 analysts cover SRTA with a consensus score of 4.2/5. Average price target: $10.
What does Strata Critical Medical, Inc. do?Strata Critical Medical (formerly Blade Air Mobility) is a time-critical logistics and clinical services provider to...
Strata Critical Medical (formerly Blade Air Mobility) is a time-critical logistics and clinical services provider to the U.S. transplant industry, operating one of the nation's largest air transport and surgical services networks for transplant hospitals and organ procurement organizations under the Trinity (Logistics) and Keystone (Clinical) brands. After divesting its legacy Passenger air mobility business to Joby Aero in August 2025 and acquiring Keystone in September 2025, the company now serves Medical Customers exclusively, making it more concentrated and less diversified than before.